National Cancer Institute; Notice of Closed Meetings, 11892 [07-1190]
Download as PDF
11892
Federal Register / Vol. 72, No. 49 / Wednesday, March 14, 2007 / Notices
Dated: March 7, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E7–4556 Filed 3–13–07; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
cprice-sewell on PROD1PC66 with NOTICES
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Home
Centered Coordinated Cancer Care System.
Date: April 4, 2007.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6116
Executive Boulevard, Conference Room 706,
Bethesda, MD 20892. (Telephone Conference
Call).
Contact Person: Gerald G. Lovinger, PhD,
Scientific Review Administrator, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 8101,
Bethesda, MD 20892–8329. 301/496–7987.
lovingeg@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Quantiative
Assay for O6—Carboxymethyl Guanine DNA
Adducts.
Date: April 5, 2007.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6116
Executive Boulevard, Conference Room 611,
Bethesda, MD 20892. (Telephone Conference
Call).
Contact Person: C. Michael Kerwin, PhD,
MPH, Scientific Review Administrator,
Special Review and Logistics Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 6116 Executive Blvd.,
VerDate Aug<31>2005
16:37 Mar 13, 2007
Jkt 211001
Rm. 8057, Bethesda, MD 20892–8329, 301–
496–7421. kerwinm@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, CA 07–032,
‘‘Improved Measures of Diet and Physical
Activity for the Genes and Environment
Initiative (GEI) (UO1)’’.
Date: April 18–19, 2007.
Time: 9 a.m. to 3:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Marriott Gaithersburg
Washingtonian Center, 951 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Thomas M. Vollberg, PhD,
Scientific Review Administrator, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd., Room 7142,
Bethesda, MD 20892. 301–594–9582.
vollbert@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: March 7, 2007.
Anna Snouffer,
Acting Director, Officer of Federal Advisory
Committee Policy.
[FR Doc. 07–1190 Filed 3–13–07; 8:45 am]
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Valerie L. Prenger, PhD,
Scientific Review Administrator, Review
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7214, Bethesda, MD 20892–7924. 301–435–
0270. prengerv@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Ancillary Studies in Clinical Trials.
Date: April 11, 2007.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Yingying Li-Smerin, MD,
PhD, Scientific Review Administrator,
Review Branch/DERA, National Heart, Lung,
and Blood Institute, 6701 Rockledge Drive,
Room 7184, Bethesda, MD 20892–7924. 301–
435–0277. lismerin@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: March 6, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–1184 Filed 3–13–07; 8:45 am]
BILLING CODE 4140–01–M
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Conference Grants (R13).
Date: April 6, 2007.
Time: 8 a.m. to 5 p.m.
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\14MRN1.SGM
14MRN1
Agencies
[Federal Register Volume 72, Number 49 (Wednesday, March 14, 2007)]
[Notices]
[Page 11892]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-1190]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Home Centered Coordinated Cancer Care System.
Date: April 4, 2007.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6116 Executive Boulevard,
Conference Room 706, Bethesda, MD 20892. (Telephone Conference
Call).
Contact Person: Gerald G. Lovinger, PhD, Scientific Review
Administrator, Special Review and Logistics Branch, Division of
Extramural Activities, National Cancer Institute, 6116 Executive
Blvd., Room 8101, Bethesda, MD 20892-8329. 301/496-7987.
lovingeg@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Quantiative Assay for O6--Carboxymethyl Guanine DNA Adducts.
Date: April 5, 2007.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6116 Executive Boulevard,
Conference Room 611, Bethesda, MD 20892. (Telephone Conference
Call).
Contact Person: C. Michael Kerwin, PhD, MPH, Scientific Review
Administrator, Special Review and Logistics Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 6116
Executive Blvd., Rm. 8057, Bethesda, MD 20892-8329, 301-496-7421.
kerwinm@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, CA 07-032, ``Improved Measures of Diet and Physical Activity
for the Genes and Environment Initiative (GEI) (UO1)''.
Date: April 18-19, 2007.
Time: 9 a.m. to 3:30 p.m.
Agenda: To review and evaluate contract proposals.
Place: Marriott Gaithersburg Washingtonian Center, 951
Washingtonian Boulevard, Gaithersburg, MD 20878.
Contact Person: Thomas M. Vollberg, PhD, Scientific Review
Administrator, Special Review and Logistics Branch, Division of
Extramural Activities, National Cancer Institute, 6116 Executive
Blvd., Room 7142, Bethesda, MD 20892. 301-594-9582.
vollbert@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: March 7, 2007.
Anna Snouffer,
Acting Director, Officer of Federal Advisory Committee Policy.
[FR Doc. 07-1190 Filed 3-13-07; 8:45 am]
BILLING CODE 4140-01-M